Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: German affirmation + Counterpart statement = over a month later, nothing

German affirmation + Counterpart statement = over a month later, nothing

posted on Mar 06, 2009 10:39AM

Announcement on February 2, 2009: The German Federal Patent Court affirmed the validity of DE 6,903,356 8T2, the German counterpart to EP 0,786,730. The affirmed German Patent and its EP counterparts cover technology utilized in a majority of microprocessor-based products manufactured and sold today. EP'730 is the European counterpart of the original MMP Portfolio application

+

“…the German proceeding was the counterpart of the USPTO patent re-examination process.”

=

Over a month later we have no new license sales announced.

Given the above, what are we to expect when the USPTO affirms our patents?

Share
New Message
Please login to post a reply